Janet H Van Cleave

Faculty

Janet Helen Van Cleave headshot

Janet H Van Cleave

MBA PhD

Assistant Professor

1 212 992 7340

433 First Ave
New York, NY 10010
United States

Accepting PhD students

Janet Helen Van Cleave, PhD, is an assistant professor at NYU Rory Meyers College of Nursing. Her program of research is focused on symptom science and mHealth technology use in cancer. She is an oncology nurse and nurse scientist whose career goal is to improve the quality of care for patients with cancer.

Van Cleave developed the Electronic Patient Visit Assessment (ePVA)© for head and neck cancer for early detection and intervention for debilitating symptoms. Her program of research has received both federal and foundation funding. She has published in high-impact scientific journals and online magazines like WIRED.

Among her many awards, she received the Poster of Distinction by the International Federation of Head and Neck Oncologic Societies and the 2014 CANCER NURSING Research Award. She was a fellow of the American Psychosocial Oncology Society Conference in New Orleans, LA.

Van Cleave received her PhD from Yale University and completed post-doctoral training at the NewCourtland Center for Transitions and Health at the University of Pennsylvania School of Nursing. She earned her MS and BS in nursing from the University of Pennsylvania.

Post-Doctoral Research Fellow - University of Pennsylvania (2010)
PhD - Yale University (2008)
MSN - University of Pennsylvania (1995)
BSN - University of Pennsylvania (Summa Cum Laude, 1994)
Diploma of Nursing - St. Luke’s Hospital School of Nursing (1983)
MBA - University of Kansas (1978)
BA - Kansas State University (1976)

Gerontology

Academy Health
American Psychosocial Oncology Society
Gerontological Society of America
International Association for the Study of Pain
Oncology Nursing Society

Mayday Pain & Society Fellowship, The Mayday Fund (2019)
ENRS/Nursing Research Authorship Award, Eastern Nursing Research Society (2017)
Poster of Distinction, International Federation of Head and Neck Oncologic Societies (2014)
Fellowship, American Psychosocial Oncology Society Conference, New Orleans, LA (2010)
Scholarship, 8th National Conference on Cancer Nursing Research, John A. Harford Foundation Policy Leadership Institute Oncology Nursing Society/American Cancer Society (2009)
Best Article, Oncology Nursing Society Special Interest Group Newsletter Editor (2004)
Outstanding Colleague, Mount Sinai Medical Center (2004)
Nominee, Clinical Excellence Award, Mount Sinai Medical Center (2002)
Unit Recognition Award for Special Clinics, Philadelphia Veterans Affairs Medical Center (2000)
Health Professional Scholarship, Department of Veterans Affairs (1994)
Joan Ethel Huebner Award for High GPA, University of Pennsylvania School of Nursing (1994)
Sigma Theta Tau, University of Pennsylvania School of Nursing (1994)

lung cancer

Van Cleave, J. H. (2004). In C. Varricchio (Ed.), A cancer source book for nurses (8th eds., pp. 215-227). Jones and Bartlett.
Abstract
Abstract
~

Lymphomas

Van Cleave, J. H. (2003). In T. Buttaro, J. Trybulski, P. P. Bailey, & J. Sandberg-Cook (Eds.), Primary care : A collaborative practice (2nd eds., pp. 1100-1105). Mosby.
Abstract
Abstract
~

Supportive care of the elderly patient with cancer

Van Cleave, J. H. (2003). (Vols. 2, pp. 44-59).
Abstract
Abstract
~

Clinical spotlight : Li-Chen Wann, RN,ANP, CCRN

Van Cleave, J. H. (2002). (Vols. 13, Issues 2, p. 2).
Abstract
Abstract
~

Learn the facts about acute tumor lysis syndrome

Van Cleave, J. H. (2002). (Vols. 13, Issues 3, pp. 3-4).
Abstract
Abstract
~

Mentor shares experience with program

Van Cleave, J. H. (2002). (Vols. 13, Issue 1, pp. 2-3).
Abstract
Abstract
~

Clinical practice highlight : NPs positively affect patients' symptom management

Van Cleave, J. H. (2001). (Vols. 12, Issues 3, pp. 1-2).
Abstract
Abstract
~

lung cancer

Van Cleave, J. H., & Cooley, M. (2001). In E. Lin (Ed.), Advanced practice in oncology nursing : Case studies & review (pp. 23-43). W.B. Saunders.
Abstract
Abstract
~

Patients with lung cancer have treatment options

Van Cleave, J. H. (2001). (Vols. 12, Issues 3, pp. 3-4).
Abstract
Abstract
~

Thalidomide is a potent angiogenesis inhibitor

Van Cleave, J. H. (2001). (Vols. 12, Issues 3, pp. 2-3).
Abstract
Abstract
~